| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |